P-LAP/IRAP-induced cell proliferation and glucose uptake in endometrial carcinoma cells via insulin receptor signaling.

P-LAP/IRAP-induced cell proliferation and glucose uptake in endometrial carcinoma cells via insulin receptor signaling.
复制标题

DOI:
10.1186/1471-2407-7-15
复制
发表时间:
2007-01-19
期刊:
影响因子:
3.8
通讯作者:
Kikkawa F
Kikkawa F
中科院分区:
医学2区
文献类型:
--
作者:
Shibata K;Kajiyama H;Ino K;Nawa A;Nomura S;Mizutani S;Kikkawa F

文献摘要

参考文献

被引文献

相似文献

高血糖或高胰岛素血症会导致子宫内膜癌生存率较差。结果表明,P-LAP/IRAP 响应胰岛素刺激而易位至质膜。最近,我们证明 P-LAP/IRAP 与子宫内膜腺癌患者的不良预后相关。本研究的目的是检查 P-LAP/IRAP 增强子宫内膜癌的恶性潜力是否是由于 P-LAP/IRAP 介导的胰岛素信号激活增加了葡萄糖摄取。我们将 P-LAP/IRAP cDNA 转染到 A-MEC 细胞(子宫内膜腺癌细胞系)中,A-MEC-LAP 细胞表达了非常高水平的 GLUT4 蛋白。 A-MEC-LAP细胞对胰岛素反应的3H-2-脱氧葡萄糖摄取显着高于A-MEC-pc细胞。与 A-MEC-pc 细胞相比,A-MEC-LAP 细胞表现出显着的生长刺激作用。与 A-MEC-pc 细胞相比,A-MEC-LAP 细胞表达显着高水平的 p85PI3K 蛋白,并且在胰岛素刺激下表现出更高程度的 AKT 磷酸化。总之,P-LAP/IRAP 参与了胰岛素介导的子宫内膜癌恶性潜能的增加。 P-LAP/IRAP被认为是子宫内膜癌分子靶向治疗的潜在新靶点。
Hyperglycemia or hyperinsulinemia contributes to poorer endometrial cancer survival. It was shown that P-LAP/IRAP translocates to the plasma membrane in response to insulin stimulation. Recently, we demonstrated that P-LAP/IRAP is associated with a poor prognosis in endometrial adenocarcinoma patients. The aim of this study was to examine whether the malignant potential of endometrial cancer enhanced by P-LAP/IRAP is due to increased glucose uptake via the P-LAP/IRAP-mediated activation of insulin signaling. We transfected P-LAP/IRAP cDNA into A-MEC cells (endometrial adenocarcinoma cell line), and A-MEC-LAP cells expressed a remarkably high level of GLUT4 proteins. 3H-2-deoxyglucose uptake which responds to insulin in A-MEC-LAP cells was significantly higher than that of A-MEC-pc cells. A-MEC-LAP cells exhibited a significant growth-stimulatory effect compared to A-MEC-pc cells. A-MEC-LAP cells expressed a remarkably high level of p85PI3K protein compared to A-MEC-pc cells, and showed a higher degree of AKT phosphorylation by insulin stimulation. In summary, P-LAP/IRAP was involved in the increasing malignant potential of endometrial cancer mediated by insulin. P-LAP/IRAP was suggested to be a potential new target of molecular-targeted therapy for endometrial cancer.
DOI: 10.1002/ijc.21509
发表时间: 2006-03-15
影响因子: 6.4
作者:
Kondo, C;Shibata, K;Kikkawa, F
通讯作者: Kikkawa, F
DOI: 10.1034/j.1600-0854.2001.20807.x
发表时间: 2001-08-01
期刊: TRAFFIC
影响因子: 4.5
作者:
Thoidis, G;Kandror, KV
通讯作者: Kandror, KV
DOI: 10.1016/j.ygyno.2004.07.054
发表时间: 2004-11-01
影响因子: 4.7
作者:
Shibata, K;Kikkawa, F;Mizutani, S
通讯作者: Mizutani, S
DOI: 10.1002/ijc.21170
发表时间: 2005-11-10
影响因子: 6.4
作者:
Oki, E;Baba, H;Maehara, Y
通讯作者: Maehara, Y
DOI: 10.1159/000078329
发表时间: 2004-01-01
期刊: ONCOLOGY
影响因子: 3.5
作者:
Shibata, K;Kikkawa, F;Mizutani, S
通讯作者: Mizutani, S